PMID: 6108392Dec 6, 1980Paper

Hepatitis B vaccine: immune responses in haemodialysis patients

Lancet
C StevensM Fotino

Abstract

Antibody to hepatitis B surface antigen (anti-HBs) developed within six months in 80% of haemodialysis patients given either two or three 40 micrograms doses of hepatitis B vaccine. A total of 89% had anti-HBs after a booster dose given six months later. Anti-HBs titres were higher in patients who received three initial doses than in those who received only two doses, but the proportion of anti-HBs-positive patients was the same in the two groups. Male patients became anti-HBs positive less often than females and their antibody titres were lower.

References

Oct 1, 1979·The Journal of Infectious Diseases·R J GeretyF J Tyeryar
Oct 20, 1977·The New England Journal of Medicine·C E Lewis, M A Lewis
Nov 17, 1978·Medical Microbiology and Immunology·P MaupasN Geslin
Jul 1, 1977·Kidney International·W T LondonB S Blumberg
May 1, 1970·The Journal of Infectious Diseases·J H WalshS A Berson

❮ Previous
Next ❯

Citations

Jul 1, 1985·European Journal of Pediatrics·U EntacherW Frisch-Niggemeyer
Mar 1, 1992·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·S L SchulmanH J Baluarte
Sep 1, 1992·Digestive Diseases and Sciences·D H Van Thiel, J S Gavaler
Aug 1, 1992·Digestive Diseases and Sciences·D H Van ThielT E Starzl
Jun 1, 1984·European Journal of Clinical Microbiology·P J GrobM Fernex
Jan 1, 1989·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·S Sklavounou-TsouroutsoglouJ Papapanayotou
Jan 3, 1981·Lancet·G D Podmore, P R Beck
Jan 3, 1981·Lancet·I Woolf
Feb 4, 1984·Lancet·S J HadziyannisK Virvidakis
Aug 23, 1984·The New England Journal of Medicine·C E StevensW Szmuness
May 1, 1992·European Journal of Clinical Investigation·M RadkowskiJ Slusarczyk
May 18, 2010·Nephrology·Matthew EdeyDavid W Johnson
Jan 18, 1986·British Medical Journal·S E BrownM W Steward
May 30, 2003·American Journal of Public Health·Paula J LumUNKNOWN UFO Study
Mar 1, 1985·Acta paediatrica Scandinavica·L M CallisR Lardinois
May 5, 2017·Viruses·Patrick T F KennedyWilliam S Mason
Oct 1, 1983·Oral Surgery, Oral Medicine, and Oral Pathology·J A Cottone, W M Goebel
Jan 1, 2015·Journal of Translational Internal Medicine·Bassam Bernieh
Mar 21, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M H Sjogren
Jul 1, 1984·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R A HeijtinkN Masurel
Nov 1, 1984·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E Celis, T W Chang
Sep 12, 2006·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Frederik NevensMichel Stoffel
Oct 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J A QuirogaA Mora
Mar 1, 1989·Infection·W JilgF Deinhardt
Aug 25, 2015·Revista chilena de pediatría·Rodolfo VillenaMaría Elena Santolaya
Jan 1, 1982·Infection·F Deinhardt
Mar 19, 2020·Human Vaccines & Immunotherapeutics·Hong ZhaoYi-Hua Zhou
Aug 19, 2015·Journal of Viral Hepatitis·A Suk-Fong Lok
Mar 15, 2019·Clinical Microbiology Reviews·Petra Zimmermann, Nigel Curtis
Mar 1, 1988·Digestive Diseases and Sciences·C MendenhallD D Morgan
Jun 28, 2002·The Annals of Pharmacotherapy·Jodi R Arrowood, Mary S Hayney
May 4, 2021·The Journal of Clinical Investigation·Tomohiro EnokidaNina Bhardwaj

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.